RADIANT-3 Trial: Everolimus in Pancreatic Neuroendocrine Tumors

0 Views
administrator
administrator
07/08/23

Jonathan Strosberg, MD, Diane Reidy-Lagunes, MD, MS, and Rodney F. Pommier, MD, discuss results from the phase III RADIANT-3 trial that explored everolimus in patients with pancreatic neuroendocrine tumors.

For more from this discussion, visit http://www.onclive.com/peer-ex....change/pancreatic-ne

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next